Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts

A randomized control trial to compare the efficacy difference between intralesional bleomycin and cryotherapy in treating plantar warts.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Viral Wart DNA Virus Infections Infections Papillomavirus Infections Skin Diseases Skin Diseases, Infectious Skin Diseases, Viral Skin and Connective Tissue Diseases Tumor Virus Infections Virus Diseases Warts

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Adeel Siddiqui

Abbottabad, KPK, Pakistan

About this study

In spite of many available studies on bleomycin and cryotherapy in treating warts, little head-to-head research is carried out to compare the efficacy of these treatments. This study shows clear difference in the clearance of warts treated with intralesional bleomycin and cryotherapy.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-healthy individuals of both genders between 18 to 50 years

Exclusion criteria

Pregnant and Lactating women
history of vascular diseases/ chilblains
Immunocompromised patients
Treated previously for warts

Treatment and study plan

COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS

Procedure

comparison of therapeutic efficacy between intralesional bleomycin and cryotherapy in plantar warts

Primary outcomes

comparative effecacy of intra lesional bleomycin vs cryotherapy in treating plantar warts within 30 days of treatment

Time frame: 30 days of treatment

Intralesional bleomycin is more effective than cryotherapy in treating plantar warts within

Sponsors and collaborators

Lead sponsor

Combined Military Hospital Abbottabad

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Mar 2, 2023
Registry last updated: Mar 2, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed